Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 2.945
-0.020 (-0.67%)
Aug 13, 2026, 5:29 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 197.87 million as of August 13, 2026. Its market cap has decreased by -33.49% in one year.
Market Cap
197.87M
Enterprise Value
180.01M
Revenue
10.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.95
ChartMarket Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 197.87M, an increase of 61.33%. That is a compound annual growth rate of 9.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 196.54M | -22.43% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 279.47M |
| IRLAB Therapeutics AB | 227.53M |
| Alzinova AB | 204.26M |
| Xbrane Biopharma AB | 197.40M |
| Initiator Pharma | 177.98M |
| Abera Bioscience AB | 173.42M |
| Xintela AB | 159.33M |
| Diamyd Medical AB | 158.70M |